Epidemiological Prevalence of Phenotypical Resistances and Mobilised Colistin Resistance in Avian Commensal and Pathogenic E. coli from Denmark, France, The Netherlands, and the UK

Colistin has been used for the treatment of non-invasive gastrointestinal infections caused by avian pathogenic E. coli (APEC). The discovery of mobilised colistin resistance (mcr) in E. coli has instigated a One Health approach to minimise colistin use and the spread of resistance. The aim of this study was to compare colistin susceptibility of APECs (collected from Denmark n = 25 and France n = 39) versus commensal E. coli (collected from the Netherlands n = 51 and the UK n = 60), alongside genetic ( mcr -1–5) and phenotypic resistance against six other antimicrobial classes (aminoglycosides... Mehr ...

Verfasser: Andrew Mead
Candice Billon-Lotz
Rikke Olsen
Ben Swift
Pascal Richez
Richard Stabler
Ludovic Pelligand
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Antibiotics, Vol 11, Iss 631, p 631 (2022)
Verlag/Hrsg.: MDPI AG
Schlagwörter: mobilised colistin resistance ( mcr ) / avian pathogenic E. coli (APEC) / E. coli / chicken / epidemiology / colistin / Therapeutics. Pharmacology / RM1-950
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29586756
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/antibiotics11050631